UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Use of rapamycin slows progression of cardiac transplantation vasculopathy

Circulation (New York, N.Y.), 2003-07, Vol.108 (1), p.48-53

2003

Volltextzugriff (PDF)

Evaluation of the safety and tolerability of a high-dose intravenous infusion of allogeneic mesenchymal precursor cells

Cytotherapy (Oxford, England), 2015-09, Vol.17 (9), p.1178-1187

2015

Volltextzugriff (PDF)

Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep

The spine journal, 2014-03, Vol.14 (3), p.435-444

2014

Volltextzugriff (PDF)

The changing pattern of humoral rejection in cardiac transplant recipients

Transplantation, 2007-08, Vol.84 (4), p.498-503

2007

Volltextzugriff (PDF)

Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascularization (GAIN I) trial

The American heart journal, 2008-11, Vol.156 (5), p.954-963

2008

Volltextzugriff (PDF)

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

Circulation research, 2015-08, Vol.117 (6), p.576-584

2015

Volltextzugriff (PDF)

RGDfK-Peptide Modified Alginate Scaffold for Cell Transplantation and Cardiac Neovascularization

Tissue engineering. Part A, 2018-05, Vol.24 (9-10), p.740-751

2018

Volltextzugriff (PDF)

Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation

American journal of respiratory and critical care medicine, 1998-06, Vol.157 (6), p.1833-1837

1998

Volltextzugriff (PDF)

Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate

Journal of neurosurgery. Spine, 2016-05, Vol.24 (5), p.715-726

2016

Volltextzugriff (PDF)

Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds

Journal of biomaterials applications, 2016-10, Vol.31 (4), p.510-520

2016

Volltextzugriff (PDF)

Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes

Diabetes & vascular disease research, 2005-05, Vol.2 (2), p.76-80

2005

Volltextzugriff (PDF)

Alloantibodies in heart transplantation

Human immunology, 2009-10, Vol.70 (10), p.825-829

2009

Volltextzugriff (PDF)

Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells

Tissue engineering. Part A, 2010-12, Vol.16 (12), p.3579-3587

2010

Volltextzugriff (PDF)

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

International journal of cardiology, 2006-04, Vol.109 (1), p.21-27

2006

Volltextzugriff (PDF)

Islet grafting and imaging in a bioengineered intramuscular space

Transplantation, 2009-11, Vol.88 (9), p.1065-1074

2009

Volltextzugriff (PDF)

Prevention of Rejection in Cardiac Transplantation by Blockade of the Interleukin-2 Receptor with a Monoclonal Antibody

The New England journal of medicine, 2000-03, Vol.342 (9), p.613-619

2000

Volltextzugriff (PDF)

Immunologic sensitization in recipients of left ventricular assist devices

The Journal of thoracic and cardiovascular surgery, 2003-03, Vol.125 (3), p.578-591

2003

Volltextzugriff (PDF)

Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction

Journal of molecular and cellular cardiology, 2005-08, Vol.39 (2), p.213-221

2005

Volltextzugriff (PDF)

Immunoglobulin m-to-immunoglobulin g anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease

Circulation (New York, N.Y.), 2005-10, Vol.112 (16), p.2468-2476

2005

Volltextzugriff (PDF)

Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients

Circulation (New York, N.Y.), 2002-03, Vol.105 (10), p.1214-1219

2002

Volltextzugriff (PDF)

Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device

The Lancet (British edition), 1999-08, Vol.354 (9178), p.550-555

1999

Volltextzugriff (PDF)

Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation

Circulation (New York, N.Y.), 1998-08, Vol.98 (8), p.786-793

1998

Volltextzugriff (PDF)

Utility of Post-Transplant Anti-HLA Antibody Measurements in Pediatric Cardiac Transplant Recipients

The Journal of heart and lung transplantation, 2005-09, Vol.24 (9), p.1289-1296

2005

Volltextzugriff (PDF)

Anti-HLA antibodies in heart transplantation

Transplant immunology, 2004, Vol.12 (2), p.177-183

2004

Volltextzugriff (PDF)

Immunoselected STRO-3+ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs

Journal of neurosurgery. Spine, 2012-05, Vol.16 (5), p.479

2012

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(39)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Use of rapamycin slows progression of cardiac transplantation vasculopathy

Evaluation of the safety and tolerability of a high-dose intravenous infusion of allogeneic mesenchymal precursor cells

Allogeneic mesenchymal progenitor cells for posterolateral lumbar spine fusion in sheep

The changing pattern of humoral rejection in cardiac transplant recipients

Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascularization (GAIN I) trial

A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart Failure

RGDfK-Peptide Modified Alginate Scaffold for Cell Transplantation and Cardiac Neovascularization

Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation

Reconstitution of degenerated ovine lumbar discs by STRO-3-positive allogeneic mesenchymal precursor cells combined with pentosan polysulfate

Optimization of alginate purification using polyvinylidene difluoride membrane filtration: Effects on immunogenicity and biocompatibility of three-dimensional alginate scaffolds

Cells expressing the stem cell factor receptor, c-kit, contribute to neoangiogenesis in diabetes

Alloantibodies in heart transplantation

Comparative assessment of the osteoconductive properties of different biomaterials in vivo seeded with human or ovine mesenchymal stem/stromal cells

Intra-coronary high-dose CD34+ stem cells in patients with chronic ischemic heart disease: A 12-month follow-up

Islet grafting and imaging in a bioengineered intramuscular space

Prevention of Rejection in Cardiac Transplantation by Blockade of the Interleukin-2 Receptor with a Monoclonal Antibody

Immunologic sensitization in recipients of left ventricular assist devices

Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction

Immunoglobulin m-to-immunoglobulin g anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease

Intravenous pulse administration of cyclophosphamide is an effective and safe treatment for sensitized cardiac allograft recipients

Activation-induced T-cell death and immune dysfunction after implantation of left-ventricular assist device

Preformed IgG antibodies against major histocompatibility complex class II antigens are major risk factors for high-grade cellular rejection in recipients of heart transplantation

Utility of Post-Transplant Anti-HLA Antibody Measurements in Pediatric Cardiac Transplant Recipients

Anti-HLA antibodies in heart transplantation

Immunoselected STRO-3+ mesenchymal precursor cells and restoration of the extracellular matrix of degenerate intervertebral discs

Aktive Filter

Suchergebnisse filtern